Novartis Pharma AG: Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU) | Two-year efficacy and safety data analyses from Phase III SUNSHINE and SUNRISE trials of continuous Cosentyx® (secukinumab) treatment in HS to be presentedNew analyses of 52-week data from Phase III... ► Artikel lesen |
Novartis Aktie: Aufwärts mit neuen Ideen | Die Novartis-Aktie verzeichnete am Freitag leichte Kursverluste im SIX SX-Handel. Am Vormittag rutschte der Kurs um 0,3 Prozent auf 97,27 CHF ab und setzte diese Tendenz auch im Tagesverlauf fort. Bis... ► Artikel lesen |
Novartis Pharma AG: Novartis oral Fabhalta (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G) | If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5
Phase... ► Artikel lesen |
Analytic Edge (a C5i company): Analytic Edge Now a Certified Partner in APAC for Google's Meridian Marketing Mix Modelling (MMM) Platform | LONDON, March 4, 2025 /PRNewswire/ -- Analytic Edge (a C5i company), a leading provider of marketing and sales analytics solutions, announced that it is now a certified partner in APAC for... ► Artikel lesen |
Alphabet Stock: AI Expansion Drives Market Position | Alphabet Inc., Google's parent company, continues to strengthen its artificial intelligence strategy through new partnerships and internal initiatives. Recently, Analytic Edge became a certified partner... ► Artikel lesen |
Analytic Edge (a C5i company): Analytic Edge Now a Certified Partner in APAC for Google's Meridian Marketing Mix Modelling (MMM) Platform | SINGAPORE, March 4, 2025 /PRNewswire/ -- Analytic Edge (a C5i company), a leading provider of marketing and sales analytics solutions, announced that it is now a certified partner in APAC... ► Artikel lesen |